PRINT ISSN 1222-5304, ISSN-L: 2065-1295, ISSN CD: 2343-9394,ISSN ONLINE 2067-3663
 

NEW COMPARATIVE THERAPEUTIC ASPECTS ON NHML IN HUMANS, DOGS AND CATS IN ORDER TO ENSURE CURABILITY GROWTH AND COMMON BIOTOPE ECO-HEALTH

Published in Scientific Works. Series C. Veterinary Medicine, Vol. LXI
Written by Dan CRÎNGANU, Rǎzvan NEGREANU, Raluca NEGREANU

Non Hodgkin malignant lymphoma ( NHML ) is not a simple malignant disease , having a varied symptomatic polymorphism based on neoplastic solid proliferation (lymphoma ) or liquid proliferation (leukemia)of the lymphocytes (mainly B ) in lymphoid tissues ( lymphnodes , spleen and thymus ) or in other tissues rich in lymphoid structures ( intestine , liver and tonsils) The natural clinical evolution (untreated) of the malignant lymphoma is multistage, advancing rapidly through progression from the first affected lymphnodes to the neighboring lymphnodes and successive invasion of the organs. NHL therapy in humans is well studied and standardized for each type of lymphoma but according to the clinical stage and the health condition of the patient. The use of combination therapy (cytostatic multi-agent therapy while ecosanitzing the biotope of the pacient) and the epidemiological investigation to identify common oncogenic factors involved in the etiopathogenesis issues are some of the objectives pursued. The results obtained by associating multimodal therapy o the patient simultaneously with ecosanitizing the living environment by avoiding or diminishing oncogenic factors could be extrapolated in the treatement of the human cancers. Identification of common oncogenic factors in human and pets habitat is a major goal, knowing that it is easier to prevent than to treat.

[Read full article] [Citation]

The publisher is not responsible for the opinions published in the Volume. They represent the authors’ point of view.

© 2019 Scientific Papers. C Series. Veterinary Medicine. All Rights Reserved. To be cited: Scientific Papers. C Series. Veterinary Medicine.

Powered by INTELIDEV